Abbott Laboratories (NYSE: ABT ) is an interesting hybrid - a large and well-established pharmaceutical company that's also proactive. The leadership is confident but realistic, anticipating challenges such as tariff imposition while mitigating potential damage via flexibility and adjustment ofI am a writer with diverse interests from creative writing to physics to tennis and music. Another interest is markets/investing. I live on the Israeli Golan Heights.I believe in research as a critical component of an ...